With almost half of American adults living with high blood pressure, it makes sense that you'd want every possible tool in your arsenal to reduce your numbers and get your blood pressure into a ...
AstraZeneca AZN announced that the FDA has approved baxdrostat for treating adult patients with uncontrolled or treatment-resistant hypertension as an add-on to other antihypertensive drugs.
Researchers explored the relationship between NSAID use and incident hypertension among younger patients with axial spondyloarthritis.
Baxdrostat, a new blood pressure drug, cut systolic BP by 9-10 mmHg in trials and may benefit Indian patients with resistant ...